Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150939 · ClinicalTrials.gov registry record · NA
Cryoablation for the Treatment of Metastatic Cancer
A NA study of Metastatic Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04150939 is a NA study of Metastatic Malignant Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants, below the 337-participant average among 15 other Metastatic Malignant Neoplasm trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04150939, a NA study of Metastatic Malignant Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This interventional trial studies the effectiveness of adding cryoablation treatment in patients who are receiving standard of care immunotherapy to treat cancer that is has spread to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue around the tumor to try to kill the cancer cells. Using cryoablation to treat cancerous lesions may help to kill the cancer cells.
Conditions Studied
Interventions
- PROCEDURE Core Biopsy
- PROCEDURE Cryosurgery
- DRUG Immunotherapeutic Agent
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-12-23 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150939
The ClinicalTrials.gov registry entry for NCT04150939 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 337-participant average among 15 other Metastatic Malignant Neoplasm trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Malignant Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Core Biopsy is the first listed.
NCT04150939 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04150939 about?
NCT04150939 is a clinical study titled "Cryoablation for the Treatment of Metastatic Cancer". This interventional trial studies the effectiveness of adding cryoablation treatment in patients who are receiving standard of care immunotherapy to treat cancer that is has spread to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue around the tumor to try to k...
What is the current status of trial NCT04150939?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2019-12-23. Estimated completion is 2026-08-31.
What conditions does trial NCT04150939 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm.
What interventions are being tested in trial NCT04150939?
The interventions under investigation include: Core Biopsy (PROCEDURE), Cryosurgery (PROCEDURE), Immunotherapeutic Agent (DRUG).
Who is sponsoring clinical trial NCT04150939?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04150939 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
ACTIVE NOT RECRUITING · NA
-
Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits
COMPLETED · NA
-
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
RECRUITING · Phase 1
-
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer
RECRUITING · Phase 2
-
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.